| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 6, Table 2
Hutlet B and Schlosser G (2025)
|
Xla Wt + pias4
NF13-14 (in situ hybridization)
|
|
|
|
Fig. 5, Table2
Hutlet B and Schlosser G (2025)
|
Xla Wt + pias4 MO
NF13-14 (in situ hybridization)
|
|
|
|
Fig. 8. Table 3
Hutlet B and Schlosser G (2025)
|
Xla Wt + smarce1
NF13-14 (in situ hybridization)
|
|
|
|
Fig. 8. Table 3
Hutlet B and Schlosser G (2025)
|
Xla Wt + smarce1
NF13-14 (in situ hybridization)
|
|
|
|
Fig. 7, Table 3
Hutlet B and Schlosser G (2025)
|
Xla Wt + smarce1 MO
NF13-14 (in situ hybridization)
|
|
|
|
Fig. 3 (neurula)
Damuth DL et al. (2024)
|
Xla Wt + Xla.sox21.S
NF15 (RT-PCR)
|
|
|
|
Fig 2 C abcd
Bou-Rouphael J et al. (2024)
|
Xla Wt + barhl1
NF45 (in situ hybridization)
|
|
|
|
Fig S3 C
Bou-Rouphael J et al. (2024)
|
Xla Wt + barhl1 MO
NF41-42 (in situ hybridization)
|
|
|
|
Fig 3 A a' a""B C D a
Bou-Rouphael J et al. (2024)
|
Xla Wt + barhl1 MO
NF45 (in situ hybridization)
|
|
|
|
Fig. S3 D
Bou-Rouphael J et al. (2024)
|
Xla Wt + barhl1 MO
NF48 (in situ hybridization)
|
|
|